Stockscreener 앱 받기
3.5005
0.29%
-0.0005
전일 마감가:
$3.50
열려 있는:
$3.45
하루 거래량:
28,381
Relative Volume:
0.03
시가총액:
$91.13M
수익:
$18.94M
순이익/손실:
$-2.71M
주가수익비율:
-25.00
EPS:
-0.14
순현금흐름:
$-4.92M
1주 성능:
+4.80%
1개월 성능:
+99.43%
6개월 성능:
+94.97%
1년 성능:
+137.41%
1일 변동 폭
$3.45
$3.52
1주일 범위
$3.28
$3.58
52주 변동 폭
$1.18
$3.78
Icad Inc Stock (ICAD) Company Profile
명칭
Icad Inc
전화
603-882-5200
주소
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH
ICAD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICAD
Icad Inc
|
3.52 | 91.13M | 18.94M | -2.71M | -4.92M | -0.14 |
|
ABT
Abbott Laboratories
|
132.20 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.72 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
373.62 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.86 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.04 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-04-17 | 다운그레이드 | Laidlaw | Buy → Hold |
| 2022-01-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-04-22 | 개시 | Guggenheim | Buy |
| 2021-03-23 | 개시 | BTIG Research | Buy |
| 2021-02-26 | 개시 | Oppenheimer | Outperform |
| 2021-01-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-12-03 | 개시 | B. Riley Securities | Buy |
| 2020-02-05 | 개시 | JMP Securities | Mkt Outperform |
| 2020-01-09 | 개시 | Lake Street | Buy |
| 2008-12-09 | 재확인 | Canaccord Adams | Buy |
| 2008-08-01 | 재확인 | MDB Capital Group | Buy |
| 2008-05-14 | 재확인 | Canaccord Adams | Buy |
| 2008-02-14 | 개시 | Sun Trust Rbsn Humphrey | Buy |
| 2007-01-24 | 재확인 | Dawson James | Speculative Buy |
모두보기
Icad Inc 주식(ICAD)의 최신 뉴스
iCAD and Microsoft join forces for AI mammography solutions - Yahoo
Brachytherapy Seeds Market Detailed In New Research Report 2025 - openPR.com
iCAD integrates mammo AI into Microsoft’s Precision Imaging Network - DOTmed
iCAD to Integrate AI Breast Cancer Detection into Microsoft’s Precision Imaging Network - HIT Consultant
iCad, Microsoft to Collaborate on Mammography Solutions - Imaging Technology News
Clinical AI Platforms Expand Globally Amid Regulatory and Market Tailwinds - The Globe and Mail
iCAD (ICAD) Partners with Microsoft to Enhance AI Mammography So - GuruFocus
iCAD Collaborates with Microsoft to provide access to its - GlobeNewswire
iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft's Precision Imaging Network (PIN) - The Manila Times
iCAD, Inc. Partners with Microsoft to Integrate AI-Powered Mammography Solutions into ProFound Breast Health Suite - Nasdaq
Microsoft and iCAD Join Forces: AI Breast Cancer Detection Gets 22% More Accurate with PowerScribe Integration - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Form 425 ICAD INC Filed by: RadNet, Inc. - StreetInsider
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, W - GuruFocus
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, WBA, RDW on Behalf of Shareholders - PR Newswire
Perkins Coie Advises RadNet, Inc. in Agreement to Acquire iCAD, Inc. - Perkins Coie
RadNet Makes An Acquisition - Los Angeles Business Journal
Dentons represents iCAD, Inc. in its definitive merger agreement with RadNet, Inc. - Dentons
U.S. Computer-Aided Detection Market Set to Witness - openPR.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, XAGE, DADA, MESA on Behalf of Shareholders - Kilgore News Herald
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of iCAD, Inc.ICAD - Eastern Progress
RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says - marketscreener.com
RadNet’s DeepHealth strikes $103m deal to acquire iCAD - Medical Device Network
ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc.ICAD - MarketScreener
BTIG Research Downgrades iCAD to Neutral From Buy - marketscreener.com
3 Promising Penny Stocks With Market Caps Under $200M - Yahoo Finance
iCAD (ICAD) Downgraded by BTIG Following Acquisition Announcemen - GuruFocus
This Microsoft Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
RadNet leaders discuss rationale behind blockbuster $103M iCAD AI acquisition - Radiology Business
iCAD (ICAD) Downgraded to Hold Following Acquisition Announcement | ICAD Stock News - GuruFocus
To speed adoption of breast cancer AI, a radiology network plots an acquisition - statnews.com
Laidlaw cuts ICAD stock rating following acquisition news By Investing.com - Investing.com India
Laidlaw cuts ICAD stock rating following acquisition news - Investing.com
RadNet to acquire iCAD, expand AI breast imaging impact - IT Brief Australia
RadNet's Bold Move: Acquiring ICad In A $103 Million Deal - Finimize
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, XAGE, DADA on Behalf of Shareholders - GlobeNewswire
BTIG cuts ICAD stock rating following RadNet acquisition plan By Investing.com - Investing.com South Africa
Radnet doubles down on breast cancer with $103M Icad buy - BioWorld MedTech
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Longevity Health Holdings, Inc. (NasdaqXAGE), iCAD, Inc. (NasdaqICAD), Beacon Roofing Supply, Inc. (NasdaqBECN), Dada Nexus Limited (NasdaqD - TradingView
BTIG cuts ICAD stock rating following RadNet acquisition plan - Investing.com
iCAD (ICAD) Stock Downgraded to Neutral Amid RadNet Acquisition - GuruFocus
RadNet Buying Breast Health Solutions Company iCAD - Healthcare Innovation
Top Midday Gainers - MarketScreener
RadNet to Acquire iCAD (ICAD) in $103M Stock Deal | ICAD Stock N - GuruFocus
RadNet to acquire iCad - MassDevice
Crude Oil Moves Higher; Travelers Earnings Beat Estimates - Benzinga
Acquisition Announcement Sparks Buying Spree For This Micro Cap - The Globe and Mail
RadNet to Acquire iCAD for $103 Million - Medical Product Outsourcing
Icad Inc (ICAD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.50%
2.00%
자본화:
|
볼륨(24시간):